Literature DB >> 19781902

Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective randomized study.

Carlos V Serrano1, Juliana A Souza, Neuza H Lopes, Juliano L Fernandes, José Carlos Nicolau, Maria Heloísa S L Blotta, José Antônio F Ramires, Whady A Hueb.   

Abstract

BACKGROUND: The effects of off-pump (OffPCABG) and on-pump (OnPCABG) coronary artery bypass grafting (CABG) on myocardium and inflammation are unclear.
OBJECTIVE: Compare the inflammatory response and myocardial injury from patients (pts) submitted to OffPCABG with those that undergo OnPCABG.
METHODS: Patients with normal left ventricular function were assigned to OffPCABG (n = 40) and OnPCABG (n = 41). Blood samples were collected before and 24 hours after surgery for determination of creatine kinase (CK)-MB (CK-MB), troponin I (cTnI), interleukin (IL)-6, IL-8, P-selectin, intercellular adhesion molecule (ICAM)-1 and C-reactive protein (CRP). Mortalities were registered at 12 months.
RESULTS: Preoperative CK-MB and cTnI levels were 3.1 +/- 0.6 IU and 1.2 +/- 0.5 ng/mL for OffPCABG and 3.0 +/- 0.5 IU and 1.0 +/- 0.2 ng/mL for OnPCABG pts. Postoperative CK-MB and cTnI levels were 13.9 +/- 6.5 IU and 19.0 +/- 9.0 ng/mL for OffPCABG vs 29.5 +/- 11.0 IU and 31.5 +/- 10.1 ng/mL for OnPCABG (P < .01). OffPCABG and OnPCABG pts had similar preoperative IL-6 (10 +/- 7 and 9 +/- 13 pg/mL), IL-8 (19 +/- 7 and 17 +/- 7 pg/mL), soluble P-selectin (70 +/- 21 and 76 +/- 23 pg/mL), soluble ICAM-1 (117 +/- 50 and 127 +/- 52 ng/mL), and CRP (0.09 +/- 0.05 and 0.11 +/- 0.07 mg/L). At 24 hours, for OffPCABG and OnPCABG: IL-6 was 37 +/- 38 and 42 +/- 41 g/mL; IL-8, 33 +/- 31 and 60 +/- 15 pg/mL; soluble P-selectin, 99 +/- 26 and 172 +/- 30 pg/mL; soluble ICAM-1, 227 +/- 47 and 236 +/- 87 ng/mL; and CRP, 10 +/- 11 and 14 +/- 13 mg/L (P < .01 vs preoperation; P < .01 vs OffPCABG). Increased 24-hour postoperative CRP levels was the only marker to have significant positive correlations with events and occurred just for the OnPCABG pts. In-hospital and 1-year mortalities for the OnPCABG and OffPCABG pts were 2.0% and 2.2% (P = .1) and 2.7% and 4.7% (P = .06), respectively.
CONCLUSIONS: Thus, the absence of CPB during CABG preserves better the myocardium and attenuates inflammation-however, without improving survival. Copyright (c) 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781902     DOI: 10.1016/j.jcrc.2009.06.009

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  13 in total

Review 1.  Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.

Authors:  R Clive Landis; Jeremiah R Brown; David Fitzgerald; Donald S Likosky; Linda Shore-Lesserson; Robert A Baker; John W Hammon
Journal:  J Extra Corpor Technol       Date:  2014-09

Review 2.  Meta-analysis of interleukin 6, 8, and 10 between off-pump and on-pump coronary artery bypass groups.

Authors:  Fanbo Meng; Jianghong Ma; Wei Wang; Baisong Lin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

3.  Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis.

Authors:  A Yousif; D Addison; N Lakkis; T Rosengart; S S Virani; Y Birnbaum; M Alam
Journal:  Ir J Med Sci       Date:  2017-09-21       Impact factor: 1.568

4.  Comparison of Adrenal Suppression between Etomidate and Dexmedetomidine in Children with Congenital Heart Disease.

Authors:  Hongbin Gu; Mazhong Zhang; Meihua Cai; Jinfen Liu
Journal:  Med Sci Monit       Date:  2015-05-29

5.  Variation of perioperative plasma mitochondrial DNA correlate with peak inflammatory cytokines caused by cardiac surgery with cardiopulmonary bypass.

Authors:  Chaoyi Qin; Ruiqi Liu; Jun Gu; Yajiao Li; Hong Qian; Yingkang Shi; Wei Meng
Journal:  J Cardiothorac Surg       Date:  2015-06-24       Impact factor: 1.637

6.  Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions.

Authors:  Ali Dabbagh; Samira Rajaei; Ayad Bahadori Monfared; Ali Asghar Keramatinia; Korosh Omidi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

7.  Acute Effect of Intravenous Administration of Magnesium Sulfate on Serum Levels of Interleukin-6 and Tumor Necrosis Factor-α in Patients Undergoing Elective Coronary Bypass Graft With Cardiopulmonary Bypass.

Authors:  Parastou Aryana; Samira Rajaei; Abdolhamid Bagheri; Forouzan Karimi; Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2014-06-17

8.  Pulmonary artery hypertension following coronary artery bypass grafting: a case report.

Authors:  Renana Robinson; Jean Marc Weinstein; Carlos Cafri; Avital Avriel
Journal:  ESC Heart Fail       Date:  2018-03-10

Review 9.  The impact of off-pump surgery in end-organ function: practical end-points.

Authors:  Haralabos Parissis; Simon Mbarushimana; Bandigowdanapalya C Ramesh; Mondrian Parissis; Savvas Lampridis; Peter Mhandu; Bassel Al-Alao
Journal:  J Cardiothorac Surg       Date:  2015-11-10       Impact factor: 1.637

Review 10.  Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders.

Authors:  Daniel P Jones; Jyoti Patel
Journal:  Biology (Basel)       Date:  2018-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.